Table 1.
Clinical Characteristics of Patients Enrolled in the Training and Test Cohorts
| Clinical Characteristics | Training Cohort | Test Cohort | ||||||
|---|---|---|---|---|---|---|---|---|
| PTC (n=52) | Thyroid Nodule (n=38) | HC (n=50) | P | PTC (n=61) | Thyroid Nodule (n=42) | HC (n=61) | P | |
| Age (years)* | 64.2±4.56 | 65.0±5.67 | 64.9±5.32 | 0.277 | 65.5±6.68 | 66.4±7.83 | 64.1±6.77 | 0.432 |
| Gender (male/female) | 27/25 | 20/18 | 20/30 | 0.381 | 29/32 | 22/20 | 25/36 | 0.508 |
| TNM staging | ||||||||
| I–II | 35 (67.31) | – | – | – | 38 (62.30) | – | – | – |
| III–IV | 17 (32.69) | – | – | – | 23 (37.70) | – | – | – |
| Multifocality | 18 (34.62) | – | – | – | 20 (32.79) | – | – | – |
| Lymph node metastasis | 32 (61.54) | – | – | – | 35 (57.38) | – | – | – |
| Distant metastasis | 4 (7.69) | – | – | – | 5 (8.20) | – | – | – |
Note: *Data were expressed as mean ± S.D.
Abbreviations: PTC, papillary thyroid cancer; HC, healthy control.